Bionomics (BNOX) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Bionomics Revenue Highlights


0

Latest Revenue (Q)

$98.94K

Main Segment (Y)

Licences

Main Geography (Y)

Licences

Bionomics Revenue by Period


Bionomics Revenue by Year

DateRevenueChange
2024-06-30--100.00%
2023-06-29$20.00K-92.31%
2022-06-30$260.00K100.00%
2021-06-30--100.00%
2020-06-30$50.00K-98.69%
2019-06-29$3.82M-56.56%
2018-06-30$8.79M-57.70%
2017-06-30$20.79M45.11%
2016-06-30$14.33M116.11%
2015-06-30$6.63M-85.21%
2014-06-30$44.81M2637.18%
2013-06-30$1.64M45.39%
2012-06-30$1.13M-64.62%
2011-06-30$3.18M6.34%
2010-06-30$2.99M-17.09%
2009-06-30$3.61M220.65%
2008-06-30$1.13M38.04%
2007-06-30$815.72K25.04%
2006-06-30$652.38K120.73%
2005-06-30$295.55K100.00%
2004-06-30--100.00%
2003-06-30$1.03M-36.20%
2002-06-30$1.61M169.05%
2001-06-30$599.00K100.00%
2000-06-30-100.00%
1999-06-30--

Bionomics generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Bionomics Revenue by Quarter

DateRevenueChange
2023-12-31$98.94K-71.26%
2023-06-30$344.23K33.21%
2023-03-31$258.41K185.87%
2022-12-31$90.40K37.15%
2022-09-30$65.91K-98.38%
2022-06-30$4.06M6065.76%
2022-03-31$65.91K-46.44%
2021-12-31$123.06K86.71%
2021-09-30$65.91K-72.79%
2021-06-30$242.21K1976.26%
2021-03-31$11.67K-97.50%
2020-12-31$466.51K3899.07%
2020-09-30$11.67K-87.88%
2020-06-30$96.25K725.05%
2020-03-31$11.67K-99.02%
2019-12-31$1.20M25.13%
2019-09-30$956.11K100.00%
2019-06-30--100.00%
2019-03-31$956.11K1.89%
2018-12-31$938.36K-
2018-09-30$938.36K-
2018-06-30$938.36K-
2018-03-31$938.36K-30.18%
2017-12-31$1.34M-
2017-09-30$1.34M-
2017-06-30$1.34M-
2017-03-31$1.34M-23.02%
2016-12-31$1.75M-
2016-09-30$1.75M-
2016-06-30$1.75M-
2016-03-31$1.75M5.34%
2015-12-31$1.66M-
2015-09-30$1.66M-
2015-06-30$1.66M-
2015-03-31$1.66M-65.37%
2014-12-31$4.79M-
2014-09-30$4.79M-
2014-06-30$4.79M-
2014-03-31$4.79M1069.19%
2013-12-31$409.30K-
2013-09-30$409.30K-
2013-06-30$409.30K-
2013-03-31$409.30K45.39%
2012-12-31$281.53K-
2012-09-30$281.53K-
2012-06-30$281.53K-
2012-03-31$281.53K-64.62%
2011-12-31$795.79K-
2011-09-30$795.79K-
2011-06-30$795.79K-
2011-03-31$795.79K6.34%
2010-12-31$748.33K-
2010-09-30$748.33K-
2010-06-30$748.33K-
2010-03-31$748.33K-17.09%
2009-12-31$902.62K-
2009-09-30$902.62K-
2009-06-30$902.62K-
2009-03-31$902.62K220.65%
2008-12-31$281.50K-
2008-09-30$281.50K-
2008-06-30$281.50K-
2008-03-31$281.50K-

Bionomics generated $98.94K in revenue during Q2 2024, up -71.26% compared to the previous quarter, and up 2.43% compared to the same period a year ago.

Bionomics Revenue Breakdown


Bionomics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 22
Licences$263.63K

Bionomics's latest annual revenue breakdown by segment (product or service), as of Jun 22: Licences (100.00%).

Bionomics Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 22
Licences$263.63K

Bionomics's latest annual revenue breakdown by geography, as of Jun 22: Licences (100.00%).

Bionomics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ADAGAdagene$18.11M$833.34K
SPRCSciSparc$2.88M$907.00K
ANEBAnebulo Pharmaceuticals--
RZLTRezolute--
BNOXBionomics-$98.94K
ANTXAN2 Therapeutics--
AVTEAerovate Therapeutics--
HILSTharimmune--
ACRVAcrivon Therapeutics--
PMVPPMV Pharmaceuticals--

BNOX Revenue FAQ


Bionomics's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $20K, representing a decrease of -92.31% compared to 2022. BNOX's yearly revenue for 2022 was $260K, representing an increase of 100.00% compared to 2021.

Bionomics's quarterly revenue for Q2 2024 was $98.94K, a -71.26% decrease from the previous quarter (Q4 2023), and a 50.11% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $344.23K, a 33.21% increase from the previous quarter (Q3 2023), and a -91.53% decrease year-over-year (Q4 2022). BNOX's quarterly revenue for Q3 2023 was $258.41K, a 185.87% increase from the previous quarter (Q2 2023), and a 292.08% increase year-over-year (Q3 2022).

Bionomics's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

Bionomics's revenue streams in n 22 are Licences

For the fiscal year ending Jun 22, the largest source of revenue of Bionomics was Licences. This segment made a revenue of $263.63K, representing 100.00% of the company's total revenue.